Metodesnitazene
| Metodesnitazene | |
|---|---|
| Salts [] | |
|---|---|
| Metodesnitazene hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 337.50 g/mol [1] |
| Predicted LogP | 4.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H27N3O |
| IUPAC name | N,N-diethyl-2-[2-[(4-methoxyphenyl)methyl]benzimidazol-1-yl]ethanamine |
| SMILES | CCN(CC)CCN1C2=CC=CC=C2N=C1CC3=CC=C(C=C3)OC |
| InChI | InChI=1S/C21H27N3O/c1-4-23(5-2)14-15-24-20-9-7-6-8-19(20)22-21(24)16-17-10-12-18(25-3)13-11-17/h6-13H,4-5,14-16H2,1-3H3 |
| InChIKey | SFNKTTXBZXVGOH-UHFFFAOYSA-N |
| CAS number | 14030-77-4 |
| UNII | TTR2RT8GBY |
| PubChem CID | 26412 |
Metodesnitazene (also known as N,n-diethyl-2-((4-methoxyphenyl)methyl)-1h-benzimidazole-1-ethanamine, 1h-benzimidazole-1-ethanamine, n,n-diethyl-2-((4-methoxyphenyl)methyl)-, N,N-diethyl-2-[(4-methoxyphenyl)methyl]-1H-benzimidazole-1-ethanamine, BENZIMIDAZOLE, 1-(2-(DIETHYLAMINO)ETHYL)-2-(p-METHOXYBENZYL)-, 1-(2-Diethylaminoethyl)-2-(p-methoxybenzyl)benzimidazole, Brn 0765000, N,N-diethyl-2-[2-(4-methoxybenzyl)-1H-benzimidazol-1-yl]ethanamine, N,N-Diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethanamine, Epitope ID:2278945 or 5-23-12-00346 (Beilstein Handbook Reference)) is a opioid substance of the phenol and nitazene class.
Chemistry
Salts []
Metodesnitazene is typically found in the form of its hydrochloride salt.
Stereochemistry []
Metodesnitazene is achiral.
Druglikeness
Lipinski's rule of five
Metodesnitazene matches Lipinski's rule of five.Subjective effects []
Legal status []
- United Kingdom: Metodesnitazene is a PSA.
- United States: Metodesnitazene is a Schedule I under the "Controlled Substances Act".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 26412, Metodesnitazene. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/26412
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metodesnitazene. UNII: TTR2RT8GBY. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/TTR2RT8GBY
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 17:00:23 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 17:00:19 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 17:00:19 |
| gsrs | ok | 2026-11-20 17:00:20 |
| hmdb | missing (no HMDB id) | 2026-11-20 17:00:19 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 17:00:23 |
| pubchem | ok | 2026-11-20 17:00:19 |
| missing (no r/tripreports posts mention it) | 2026-11-20 17:00:19 | |
| sider | missing (not in SIDER) | 2026-11-20 17:00:19 |
| structure | ok | 2026-11-20 17:00:19 |
| wikipedia | ok | 2026-11-20 17:00:19 |